NCT05683808View on ClinicalTrials.gov

Venous Thromboembolism Prevention in Outpatients With Glioma

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 16, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

December 31, 2024

Conditions
GlioblastomaAstrocytomaVenous Thromboembolism
Interventions
DRUG

Apixaban

Open label

Sponsors

Collaborators (1)

MaineHealth
All Listed Sponsors
collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

MaineHealth

OTHER

lead

University of Vermont Medical Center

OTHER